EyePod

The lacrimal functional unit, which includes the lacrimal glands and meibomian glands, can be stimulated via the trigeminal nerve to trigger production of the tear film. This approach can be used to manage dry eye disease (DED) in patients undergoing corneal refractive surgery. In this podcast, an expert explores opportunities to use this approach to treat patients with DED.

The 14th annual Glaucoma 360 conference will take place February 6 to 8, 2025, at the Westin St. Francis on Union Square in San Francisco, California. Co-founded by Adrienne Graves, PhD, and Andrew Iwach, MD, and hosted by Glaucoma Research Foundation, the three-day event highlights progress in glaucoma care while fostering innovation and collaboration. The conference opens on Thursday, February 6...

The EnVision Summit, co-founded by Bonnie An Henderson, MD, is a unique family-friendly, multispecialty CME ophthalmology conference, along with a newly introduced optometry track. Henderson sits down with Ophthalmology Times ' Sheryl Stevenson, group editorial director - eye care, to talk about the 2025 conference that will take place February 14 to 17 at the Caribe Hilton San Juan, in Puerto Ric...

Robert T. Chang, MD, from Stanford University discusses the evolving role of large language models (LLMs) in glaucoma care. He explores how these AI tools, including popular systems like ChatGPT, can enhance communication and patient education by summarizing complex information and tailoring it to different literacy levels.  Chang highlights the potential of LLMs in improving efficiency in ophthal...

In this third of an exclusive three-part Ophthalmology Times EyePod podcast series on innovation, we continue our discussion with Jibran Sharieff, MD, and Brandon Kingrey, MD, who are residents at the Dean McGee Eye Institute (DMEI) in Oklahoma City, Oklahoma. They recently won second place at the Eyecelerator competition held before this fall’s American Academy of Ophthalmology conference in Chic...

In this second of an exclusive three-part Ophthalmology Times EyePod podcast series on innovation, we continue our discussion with Jibran Sharieff, MD, and Brandon Kingrey, MD, who are residents at the Dean McGee Eye Institute (DMEI) in Oklahoma City, Oklahoma. They recently won second place at the Eyecelerator competition held before this fall’s American Academy of Ophthalmology conference in Chi...

In this first of an exclusive three-part Ophthalmology Times EyePod podcast series on innovation, we meet Jibran Sharieff, MD, and Brandon Kingrey, MD, who are residents at the Dean McGee Eye Institute (DMEI) in Oklahoma City, Oklahoma. They recently won second place at the Eyecelerator competition held prior to this month's American Academy of Ophthalmology conference in Chicago, receiving a $15,...

Take a look at a review of the highlights from Ophthalmology Times during the week of September 29, 2024. 

Peter J. McDonnell, MD, and Laura M. Periman, MD, discuss how artificial intelligence (AI) is transforming ophthalmology, especially in ocular surface disease. Dr. Periman highlights the potential of AI to streamline eye health screening and documentation, enabling ophthalmologists to focus on patients who require treatment. They emphasize how AI can enhance clinical efficiency, improve patient ou...

Take a look at a review of the highlights from Ophthalmology Times during the week of September 29, 2024. 

Take a look at a review of the highlights from Ophthalmology Times during the week of September 22, 2024. 

Ehsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, Department of Ophthalmology, Faculty of Medical and Health Sciences, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias. Green outlines the status of t...

Take a look at a review of the highlights from Ophthalmology Times during the week of September 15, 2024. 

X-linked retinitis pigmentosa (XLRP) is a progressive disease that is more severe than other forms of RP. Affected male patients typically inherit a pathogenic variant of the RPGR gene on the X chromosome. In this podcast, an expert panel discusses diagnosing XLRP and provides an overview of clinical trials of gene therapies for XLRP. 

Thyroid eye disease is a condition frequently associated with Graves disease that involves both acute and chronic inflammation of the orbit. Patients may experience ocular discomfort, appearance changes, and vision loss. In this podcast, an expert panel discusses diagnosing TED and providing appropriate pharmacologic and surgical treatments. 

John Kitchens, MD, is joined by Peter Kaiser, MD, to discuss higher molar dose and its translation into clinical practice

John Kitchens, MD, sits down with Diana Do, MD, to discuss the PHOTON results and their relation to patients with diabetic macular edema in clinical practice.

John Kitchens, MD, sits down with David Brown, MD, to discuss the PULSAR results and their relation to patients with neovascular age-related macular degeneration in clinical practice.  

This PER On Air - Ophthalmology Times podcast examines the new treatment paradigm for patients with geographic atropy, following the introduction of complement-targeting therapies. In this podcast, experts, Dr Cecelia Koetting and Dr Talia Kaden review some of the key highlights from the live satellite symposium, Community Practice Connection™: Mastering the New Treatment Paradigm in Geographic At...

In this PER On Air Ophthalmology Times podcast, a team of experts provides insights into the diagnosis and management of patients with NK (including assessing their underlying cause of NK), with a look at the range of treatments available for patients with advanced stages of NK.

In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment. Faculty: Roger A. Goldberg, MD, MBA Vitreoretinal Specialist Bay Area Retina Associates Volunteer Faculty Californ...

In this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, to learn about the progress in developing a stem cell patch for treating advanced dry age-related macular degeneration. Developed by a team of researchers at USC, the stem cell patch represents a significant advancement in treatment. Dr. Humayun talks about the inspiration behind the patch,...

This podcast features engaging commentary from experts in the clinical management of glaucoma. These experts share information about traditional and newer therapies for glaucoma, including topical drops, sustained drug delivery options, and minimally invasive glaucoma surgery. They discuss safety and efficacy data with an emphasis on appropriate patient selection, as well as key take-home points a...

The role of calendars may be growing more important when managing patients with nAMD and DME. How many weeks can patients go between injections with newer anti-VEGF agents versus older options? How short of an injection interval can patients tolerate before it becomes too much of a burden? In this podcast, Murtaza Adam, MD; Laxmi Devisetty, MD, Hong-Uyen Hua, MD; and Sherrol Reynolds, OD; share in...

Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis